What human blood-brain barrier models can tell us about BBB function and drug discovery?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 6, 2019 Category: Drugs & Pharmacology Authors: Lino Ferreira Source Type: research

Advances with weak affinity chromatography for fragment screening
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 5, 2019 Category: Drugs & Pharmacology Authors: Fotios Tsopelas Anna Tsantili-Kakoulidou Source Type: research

How can monoclonal antibodies be harnessed against neglected tropical diseases and other infectious diseases?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 31, 2019 Category: Drugs & Pharmacology Authors: Andreas H. Laustsen Source Type: research

Novel approaches to anti-obesity drug discovery with gut hormones over the past 10 years
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 29, 2019 Category: Drugs & Pharmacology Authors: Frances Rose Stephen Bloom Tricia Tan Source Type: research

Recent advances in computational design of potent aromatase inhibitors: open-eye on endocrine-resistant breast cancers
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 24, 2019 Category: Drugs & Pharmacology Authors: Angelo Spinello Ida Ritacco Alessandra Magistrato Source Type: research

Developments with bead-based screening for novel drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 23, 2019 Category: Drugs & Pharmacology Authors: Dehua Pei George Appiah Kubi Source Type: research

The human gut microbiome – a new and exciting avenue in cardiovascular drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 18, 2019 Category: Drugs & Pharmacology Authors: Yu Du Xingxing Li Chunyan Su Li Wang Jiandong Jiang Bin Hong Source Type: research

Design of α-helical antimicrobial peptides with a high selectivity index
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 17, 2019 Category: Drugs & Pharmacology Authors: Davor Jureti ć Juraj Simuni ć Source Type: research

Challenges to drug discovery for celiac disease and approaches to overcome them
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 17, 2019 Category: Drugs & Pharmacology Authors: Luis Vaquero David Bernardo Francisco Le ón Laura Rodr íguez-Martín Bego ña Alvarez-Cuenllas Santiago Vivas Source Type: research

Design of α-helical antimicrobial peptides with a high selectivity index
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 17, 2019 Category: Drugs & Pharmacology Authors: Davor Jureti ć Juraj Simuni ć Source Type: research

Challenges to drug discovery for celiac disease and approaches to overcome them
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 17, 2019 Category: Drugs & Pharmacology Authors: Luis Vaquero David Bernardo Francisco Le ón Laura Rodr íguez-Martín Bego ña Alvarez-Cuenllas Santiago Vivas Source Type: research

Transforming cancer drug discovery with Big Data and AI
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 9, 2019 Category: Drugs & Pharmacology Authors: Paul Workman Albert A. Antolin Bissan Al-Lazikani Source Type: research

Computational re-design of protein structures to improve solubility
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 8, 2019 Category: Drugs & Pharmacology Authors: Susanna Navarro Salvador Ventura Source Type: research

Can 4D bioprinting revolutionize drug development?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 8, 2019 Category: Drugs & Pharmacology Authors: Izeia Lukin Saioa Musquiz Itsasne Erezuma Taleb H. Al-Tel Nasim Golafshan Alireza Dolatshahi-Pirouz Gorka Orive Source Type: research

Computational re-design of protein structures to improve solubility
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 8, 2019 Category: Drugs & Pharmacology Authors: Susanna Navarro Salvador Ventura Source Type: research

Can 4D bioprinting revolutionize drug development?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 8, 2019 Category: Drugs & Pharmacology Authors: Izeia Lukin Saioa Musquiz Itsasne Erezuma Taleb H. Al-Tel Nasim Golafshan Alireza Dolatshahi-Pirouz Gorka Orive Source Type: research

Animal models of synucleinopathies and how they could impact future drug discovery and delivery efforts
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 5, 2019 Category: Drugs & Pharmacology Authors: Kurt A. Jellinger Source Type: research

Novel screening approaches for human prion diseases drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 4, 2019 Category: Drugs & Pharmacology Authors: Fabio Moda Maria Laura Bolognesi Giuseppe Legname Source Type: research

Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 3, 2019 Category: Drugs & Pharmacology Authors: Paolo Guglielmi Simone Carradori Alessandra Ammazzalorso Daniela Secci Source Type: research

How do we choose the appropriate animal model for antiseizure therapy development?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 28, 2019 Category: Drugs & Pharmacology Authors: Melissa Barker-Haliski Source Type: research

Repositioning rifamycins for Mycobacterium abscessus lung disease
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 14, 2019 Category: Drugs & Pharmacology Authors: Uday S. Ganapathy V éronique Dartois Thomas Dick Source Type: research

Chikungunya virus drug discovery: still a long way to go?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 14, 2019 Category: Drugs & Pharmacology Authors: Mar ía-Jesús Pérez-Pérez Leen Delang Lisa F. P. Ng Eva-Mar ía Priego Source Type: research

Repositioning rifamycins for Mycobacterium abscessus lung disease
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 14, 2019 Category: Drugs & Pharmacology Authors: Uday S. Ganapathy V éronique Dartois Thomas Dick Source Type: research

Chikungunya virus drug discovery: still a long way to go?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 14, 2019 Category: Drugs & Pharmacology Authors: Mar ía-Jesús Pérez-Pérez Leen Delang Lisa F. P. Ng Eva-Mar ía Priego Source Type: research

An outlook on using serial femtosecond crystallography in drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 11, 2019 Category: Drugs & Pharmacology Authors: Alexey Mishin Anastasiia Gusach Aleksandra Luginina Egor Marin Valentin Borshchevskiy Vadim Cherezov Source Type: research

Cell death assays for neurodegenerative disease drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 10, 2019 Category: Drugs & Pharmacology Authors: Jeremy W. Linsley Terry Reisine Steven Finkbeiner Source Type: research

Approaching Target Selectivity by De Novo Drug Design
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 10, 2019 Category: Drugs & Pharmacology Authors: Thomas Fischer Silvia Gazzola Rainer Riedl Source Type: research

Cell death assays for neurodegenerative disease drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 10, 2019 Category: Drugs & Pharmacology Authors: Jeremy W. Linsley Terry Reisine Steven Finkbeiner Source Type: research

Approaching Target Selectivity by De Novo Drug Design
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 10, 2019 Category: Drugs & Pharmacology Authors: Thomas Fischer Silvia Gazzola Rainer Riedl Source Type: research

Contemporary medicinal-chemistry strategies for discovery of blood coagulation factor Xa inhibitors
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 7, 2019 Category: Drugs & Pharmacology Authors: Xia Hao Xiaofang Zuo Dongwei Kang Jian Zhang Yuning Song Xinyong Liu Peng Zhan Source Type: research

Developments with multi-target drugs for Alzheimer ’s disease: an overview of the current discovery approaches
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 5, 2019 Category: Drugs & Pharmacology Authors: Juan F. Gonz ález Andr és R. Alcántara Antonio L. Doadrio Jose Mar ía Sánchez-Montero Source Type: research

New approaches to discovering drugs that treat dystonia
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 4, 2019 Category: Drugs & Pharmacology Authors: Sarah Pirio Richardson H. A. Jinnah Source Type: research

Have nanomedicines progressed as much as we ’d hoped for in drug discovery and development?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 4, 2019 Category: Drugs & Pharmacology Authors: Bruno Sarmento Source Type: research